DiagnaMed Announces LIFE Offering of up to $650,000
15 mai 2024 18h10 HE
|
DiagnaMed Holdings Corp.
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
15 mai 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
25 avr. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI,...
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
23 avr. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
Clinics can apply at BrainAge.ca TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company...
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
03 avr. 2024 09h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, today announced...
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
20 mars 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, announced its...
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
14 mars 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to...
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
11 mars 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to...
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
28 févr. 2024 07h30 HE
|
DiagnaMed Holdings Corp.
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain...
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
17 janv. 2024 07h30 HE
|
DiagnaMed Holdings Corp.
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain...